View in EDS

A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers.

Saved in:
Bibliographic Details
Title: A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers.
Authors: Jeong, Angela1 (AUTHOR), Weisel, Kathleen2 (AUTHOR), Dimitrova, Dessislava2 (AUTHOR), Donnelly, Brianna3 (AUTHOR), Wang, Daniel4 (AUTHOR), Vermeulen, An5 (AUTHOR), Xu, Zhenhua1 (AUTHOR) zxu5@its.jnj.com
Source: Clinical Pharmacology in Drug Development. Jan2026, Vol. 15 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Description
ISSN:2160763X
DOI:10.1002/cpdd.70007